Prostate cancer is poised to become a significant global health challenge in the coming decades, with projections indicating a staggering increase in both cases and deaths by 2040. A recent report by The Lancet Commission on prostate cancer warns of a more than doubling of prostate cancer cases worldwide, accompanied by an 85% rise in mortality rates between 2020 and 2040. Shockingly, low- and middle-income countries (LMICs) are expected to bear the brunt of this surge, emphasizing the urgent need for proactive measures to address this impending crisis.

Lead author of the commission, Professor Nick James from The Institute of Cancer Research, London, emphasizes the inevitability of this surge in prostate cancer cases. “As more and more men around the world live to middle and old age, there will be an inevitable rise in the number of prostate cancer cases. We know this surge in cases is coming, so we need to start planning and take action now,” Professor James stressed.

The commission showcases the critical importance of evidence-based interventions to combat prostate cancer, including early detection and diagnosis, along with comprehensive education and awareness programs. It is imperative to equip healthcare systems with the necessary resources and infrastructure to tackle this impending surge effectively.

Of particular concern is the lack of awareness about the dangers and symptoms of metastatic prostate cancer in LMICs. The commission calls for urgent efforts to improve awareness levels among men and their families, especially regarding symptoms such as bone pain, which often indicate advanced disease.

Furthermore, there is an urgent need to enhance diagnostic capacity and expand access to treatments for advanced prostate cancer in LMICs. By scaling up availability and improving access to essential treatments, we can ensure that all individuals, regardless of their geographical location or socioeconomic status, receive timely and adequate care.

Globally, the burden of prostate cancer is substantial, with an estimated 1.4 million new cases and 375,000 deaths reported in 2020 alone. However, these numbers are projected to more than double by 2040, with an estimated 2.9 million new cases and nearly 700,000 deaths annually. This alarming trend highlights the pressing need for coordinated global action to address the growing challenge of prostate cancer.

The Lancet Commission on prostate cancer, which includes researchers from the International Agency for Research on Cancer (IARC), stresses the importance of collaborative efforts to mitigate the impact of this disease. By prioritizing early detection, improving awareness, and expanding access to treatment, we can effectively combat prostate cancer and save countless lives in the years to come. It is imperative that we act swiftly and decisively to confront this looming public health crisis head-on.